An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria

Chronic urticaria (CU) is a rare disease in childhood, and studies in children are limited. In this study, the aim was to investigate the clinical and laboratory findings and demographic characteristics of children with CU and to determine the factors affecting prognosis. The study included 141 pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic therapy 2022-03, Vol.35 (3), p.e15261-n/a
Hauptverfasser: Özen, Burçin, Sancakli, Ozlem, Duman Senol, Handan, Ozdogru, Emine Ece, Tuncel, Tuba
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 3
container_start_page e15261
container_title Dermatologic therapy
container_volume 35
creator Özen, Burçin
Sancakli, Ozlem
Duman Senol, Handan
Ozdogru, Emine Ece
Tuncel, Tuba
description Chronic urticaria (CU) is a rare disease in childhood, and studies in children are limited. In this study, the aim was to investigate the clinical and laboratory findings and demographic characteristics of children with CU and to determine the factors affecting prognosis. The study included 141 patients aged 0–18 years who were diagnosed with CU in the pediatric allergy outpatient clinic between January 1, 2013, and December 31, 2018. Risk factors related to prognosis were investigated by comparing the duration of CU and treatment response with clinical and etiological features. IBM SPSS version 24 was used for statistical analyses. In the study group, the female/male ratio was 69/55, and the median age at first visit was 9.5 years (min:1, max:17). Among patients, 63 (44.5%) had an accompanying atopic disease, and 23 (16.3%) had chronic disease. Of the patients, 124 (88%) had chronic spontaneous urticaria, and 17 patients (12%) had chronic inducible urticaria (CIU). Of those with CIU, 72.2% had symptomatic dermographism, 16.7% had cholinergic urticaria, and 11.1% had cold urticaria. After the evaluations, the most common pathological findings in our patients were intestinal parasitosis (n = 14), anemia (n = 10), and urinary tract infection (n = 8). The median total duration of urticaria was 47 weeks (min:8, max:284). The duration of urticaria was longer in patients with atopy (p 
doi_str_mv 10.1111/dth.15261
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610411574</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610411574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3601-789d094827f33853cc921de759f117b9a0764528ffcea34da2088733551f206b3</originalsourceid><addsrcrecordid>eNp1kctOQyEQhonRaL0sfAHDUhOPcjk3lo33pIkbXZ9QztBiKFTgaPoYvrHYVneymYF8-TLMj9ApJVc0n-s-za9oxWq6g0a5iqIlVOzmnou6IEzUB-gwxjdCKBOc7qMDXgrS1Kweoa-xw_Ah7SCT8Q57jdMcsJYq-RCx1BpUMm62flXWOKOkxdL12MqpDzJTK6yN6zMTL_Ey-Jnz0eT2h0kBZFqASzhAXHoXARuH1dzYPoDDnybN8y34bMVDSNkdjDxGe1raCCfbeoRe7-9ebh6LyfPD0814UiheE1o0reiJKFvWaM7biislGO2hqYSmtJkKmT9YVqzVWoHkZS8ZaduG86qimpF6yo_Q-cabh34fIKZuYaICa6UDP8Qur5OUlFZNmdGLDaqCjzGA7pbBLGRYdZR0Pwl0OYFunUBmz7baYbqA_o_8XXkGrjfAp7Gw-t_U3b48bpTf8eyRfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610411574</pqid></control><display><type>article</type><title>An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria</title><source>Wiley Journals</source><creator>Özen, Burçin ; Sancakli, Ozlem ; Duman Senol, Handan ; Ozdogru, Emine Ece ; Tuncel, Tuba</creator><creatorcontrib>Özen, Burçin ; Sancakli, Ozlem ; Duman Senol, Handan ; Ozdogru, Emine Ece ; Tuncel, Tuba</creatorcontrib><description>Chronic urticaria (CU) is a rare disease in childhood, and studies in children are limited. In this study, the aim was to investigate the clinical and laboratory findings and demographic characteristics of children with CU and to determine the factors affecting prognosis. The study included 141 patients aged 0–18 years who were diagnosed with CU in the pediatric allergy outpatient clinic between January 1, 2013, and December 31, 2018. Risk factors related to prognosis were investigated by comparing the duration of CU and treatment response with clinical and etiological features. IBM SPSS version 24 was used for statistical analyses. In the study group, the female/male ratio was 69/55, and the median age at first visit was 9.5 years (min:1, max:17). Among patients, 63 (44.5%) had an accompanying atopic disease, and 23 (16.3%) had chronic disease. Of the patients, 124 (88%) had chronic spontaneous urticaria, and 17 patients (12%) had chronic inducible urticaria (CIU). Of those with CIU, 72.2% had symptomatic dermographism, 16.7% had cholinergic urticaria, and 11.1% had cold urticaria. After the evaluations, the most common pathological findings in our patients were intestinal parasitosis (n = 14), anemia (n = 10), and urinary tract infection (n = 8). The median total duration of urticaria was 47 weeks (min:8, max:284). The duration of urticaria was longer in patients with atopy (p &lt; 0.05), and the group that went into remission with standard‐dose antihistamine was the group with highest eosinophil count (p = 0.022). In most children with CU, the underlying cause/disease cannot be determined. In our study, treatable triggers were found in some of the patients. Therefore, it is appropriate for each patient to be evaluated with selected laboratory tests after detailed history and physical examination.</description><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.15261</identifier><identifier>PMID: 34907626</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>children ; treatment ; urticaria</subject><ispartof>Dermatologic therapy, 2022-03, Vol.35 (3), p.e15261-n/a</ispartof><rights>2021 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3601-789d094827f33853cc921de759f117b9a0764528ffcea34da2088733551f206b3</citedby><cites>FETCH-LOGICAL-c3601-789d094827f33853cc921de759f117b9a0764528ffcea34da2088733551f206b3</cites><orcidid>0000-0003-2489-4021</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.15261$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.15261$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34907626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özen, Burçin</creatorcontrib><creatorcontrib>Sancakli, Ozlem</creatorcontrib><creatorcontrib>Duman Senol, Handan</creatorcontrib><creatorcontrib>Ozdogru, Emine Ece</creatorcontrib><creatorcontrib>Tuncel, Tuba</creatorcontrib><title>An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><description>Chronic urticaria (CU) is a rare disease in childhood, and studies in children are limited. In this study, the aim was to investigate the clinical and laboratory findings and demographic characteristics of children with CU and to determine the factors affecting prognosis. The study included 141 patients aged 0–18 years who were diagnosed with CU in the pediatric allergy outpatient clinic between January 1, 2013, and December 31, 2018. Risk factors related to prognosis were investigated by comparing the duration of CU and treatment response with clinical and etiological features. IBM SPSS version 24 was used for statistical analyses. In the study group, the female/male ratio was 69/55, and the median age at first visit was 9.5 years (min:1, max:17). Among patients, 63 (44.5%) had an accompanying atopic disease, and 23 (16.3%) had chronic disease. Of the patients, 124 (88%) had chronic spontaneous urticaria, and 17 patients (12%) had chronic inducible urticaria (CIU). Of those with CIU, 72.2% had symptomatic dermographism, 16.7% had cholinergic urticaria, and 11.1% had cold urticaria. After the evaluations, the most common pathological findings in our patients were intestinal parasitosis (n = 14), anemia (n = 10), and urinary tract infection (n = 8). The median total duration of urticaria was 47 weeks (min:8, max:284). The duration of urticaria was longer in patients with atopy (p &lt; 0.05), and the group that went into remission with standard‐dose antihistamine was the group with highest eosinophil count (p = 0.022). In most children with CU, the underlying cause/disease cannot be determined. In our study, treatable triggers were found in some of the patients. Therefore, it is appropriate for each patient to be evaluated with selected laboratory tests after detailed history and physical examination.</description><subject>children</subject><subject>treatment</subject><subject>urticaria</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kctOQyEQhonRaL0sfAHDUhOPcjk3lo33pIkbXZ9QztBiKFTgaPoYvrHYVneymYF8-TLMj9ApJVc0n-s-za9oxWq6g0a5iqIlVOzmnou6IEzUB-gwxjdCKBOc7qMDXgrS1Kweoa-xw_Ah7SCT8Q57jdMcsJYq-RCx1BpUMm62flXWOKOkxdL12MqpDzJTK6yN6zMTL_Ey-Jnz0eT2h0kBZFqASzhAXHoXARuH1dzYPoDDnybN8y34bMVDSNkdjDxGe1raCCfbeoRe7-9ebh6LyfPD0814UiheE1o0reiJKFvWaM7biislGO2hqYSmtJkKmT9YVqzVWoHkZS8ZaduG86qimpF6yo_Q-cabh34fIKZuYaICa6UDP8Qur5OUlFZNmdGLDaqCjzGA7pbBLGRYdZR0Pwl0OYFunUBmz7baYbqA_o_8XXkGrjfAp7Gw-t_U3b48bpTf8eyRfA</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Özen, Burçin</creator><creator>Sancakli, Ozlem</creator><creator>Duman Senol, Handan</creator><creator>Ozdogru, Emine Ece</creator><creator>Tuncel, Tuba</creator><general>John Wiley &amp; Sons, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2489-4021</orcidid></search><sort><creationdate>202203</creationdate><title>An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria</title><author>Özen, Burçin ; Sancakli, Ozlem ; Duman Senol, Handan ; Ozdogru, Emine Ece ; Tuncel, Tuba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3601-789d094827f33853cc921de759f117b9a0764528ffcea34da2088733551f206b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>children</topic><topic>treatment</topic><topic>urticaria</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özen, Burçin</creatorcontrib><creatorcontrib>Sancakli, Ozlem</creatorcontrib><creatorcontrib>Duman Senol, Handan</creatorcontrib><creatorcontrib>Ozdogru, Emine Ece</creatorcontrib><creatorcontrib>Tuncel, Tuba</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özen, Burçin</au><au>Sancakli, Ozlem</au><au>Duman Senol, Handan</au><au>Ozdogru, Emine Ece</au><au>Tuncel, Tuba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2022-03</date><risdate>2022</risdate><volume>35</volume><issue>3</issue><spage>e15261</spage><epage>n/a</epage><pages>e15261-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><abstract>Chronic urticaria (CU) is a rare disease in childhood, and studies in children are limited. In this study, the aim was to investigate the clinical and laboratory findings and demographic characteristics of children with CU and to determine the factors affecting prognosis. The study included 141 patients aged 0–18 years who were diagnosed with CU in the pediatric allergy outpatient clinic between January 1, 2013, and December 31, 2018. Risk factors related to prognosis were investigated by comparing the duration of CU and treatment response with clinical and etiological features. IBM SPSS version 24 was used for statistical analyses. In the study group, the female/male ratio was 69/55, and the median age at first visit was 9.5 years (min:1, max:17). Among patients, 63 (44.5%) had an accompanying atopic disease, and 23 (16.3%) had chronic disease. Of the patients, 124 (88%) had chronic spontaneous urticaria, and 17 patients (12%) had chronic inducible urticaria (CIU). Of those with CIU, 72.2% had symptomatic dermographism, 16.7% had cholinergic urticaria, and 11.1% had cold urticaria. After the evaluations, the most common pathological findings in our patients were intestinal parasitosis (n = 14), anemia (n = 10), and urinary tract infection (n = 8). The median total duration of urticaria was 47 weeks (min:8, max:284). The duration of urticaria was longer in patients with atopy (p &lt; 0.05), and the group that went into remission with standard‐dose antihistamine was the group with highest eosinophil count (p = 0.022). In most children with CU, the underlying cause/disease cannot be determined. In our study, treatable triggers were found in some of the patients. Therefore, it is appropriate for each patient to be evaluated with selected laboratory tests after detailed history and physical examination.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34907626</pmid><doi>10.1111/dth.15261</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2489-4021</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1396-0296
ispartof Dermatologic therapy, 2022-03, Vol.35 (3), p.e15261-n/a
issn 1396-0296
1529-8019
language eng
recordid cdi_proquest_miscellaneous_2610411574
source Wiley Journals
subjects children
treatment
urticaria
title An evaluation of the factors affecting the clinical and laboratory findings, prognosis, and treatment response in children with chronic urticaria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A38%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20evaluation%20of%20the%20factors%20affecting%20the%20clinical%20and%20laboratory%20findings,%20prognosis,%20and%20treatment%20response%20in%20children%20with%20chronic%20urticaria&rft.jtitle=Dermatologic%20therapy&rft.au=%C3%96zen,%20Bur%C3%A7in&rft.date=2022-03&rft.volume=35&rft.issue=3&rft.spage=e15261&rft.epage=n/a&rft.pages=e15261-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.15261&rft_dat=%3Cproquest_cross%3E2610411574%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610411574&rft_id=info:pmid/34907626&rfr_iscdi=true